Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- ONT.LSE
- Price
- 132.30
- Stock movement up
- +3.50 (2.72%)
- Company name
- Oxford Nanopore Technologies Ltd
- Exchange
- (LSE ,
- Currency
- GBX )
- Sector
- Healthcare >Biotechnology
- Market cap
- 1.28B
- Ent value
- 1.26B
- Price/Sales
- 3.14
- Price/Book
- 2.76
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 14.40%
- 1 year return (CAGR)
- 4.17%
- 3 year return (CAGR)
- -16.65%
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-03-11
DIVIDENDS
ONT.LSE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 3.14 |
| Price to Book | 2.76 |
| EV to Sales | 3.09 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 966.91M |
| EPS (TTM) | -0.30 |
| FCF per share (TTM) | -0.19 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 407.09M |
| Gross profit (TTM) | 236.69M |
| Operating income (TTM) | -307.63M |
| Net income (TTM) | -291.39M |
| EPS (TTM) | -0.30 |
| EPS (1y forward) | -0.07 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 58.14% |
| Operating margin (TTM) | -75.57% |
| Profit margin (TTM) | -71.58% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 181.10M |
| Net receivables | 66.60M |
| Total current assets | 420.00M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 622.50M |
| Accounts payable | 18.40M |
| Short/Current long term debt | 41.50M |
| Total current liabilities | 118.00M |
| Total liabilities | 159.20M |
| Shareholder's equity | 463.30M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -163.18M |
| Capital expenditures (TTM) | 17.44M |
| Free cash flow (TTM) | -178.22M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -62.89% |
| Return on Assets | -46.81% |
| Return on Invested Capital | -62.20% |
| Cash Return on Invested Capital | -38.04% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 126.30 |
| Daily high | 133.37 |
| Daily low | 126.00 |
| Daily Volume | 1.12M |
| All-time high | 219.00 |
| 1y analyst estimate | 205.25 |
| Beta | 0.83 |
| EPS (TTM) | -0.30 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 2 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ONT.LSE | S&P500 | |
| Current price drop from All-time high | -39.59% | -1.82% |
| Highest price drop | -87.91% | -56.47% |
| Date of highest drop | 25 Jun 2024 | 9 Mar 2009 |
| Avg drop from high | -62.05% | -10.84% |
| Avg time to new high | 138 days | 12 days |
| Max time to new high | 919 days | 1805 days |
COMPANY DETAILS
Marketcap
1.28B
Marketcap category
Small-cap
Description
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA. It offers MinION Mk 1D, a portable device for DNA and RNA; GridION and GridION Q, a compact bench top device, which delivers a version of hardware, software, and chemistry. The company also provides PromethION 2 Solo, PromethION 2, PromethION 24, and PromethION 48. Its platform enables its customers to perform scientific/biomedical research in a various area, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. It operates in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.
Employees
1325
Website
Investor relations
-
SEC filings
CEO
Country
UK
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found